Cookie Img
Home » Products » Anticancer Drugs » Iressa 250mg - Gefitinib Tablets

Iressa 250mg - Gefitinib Tablets

Iressa 250mg - Gefitinib Tablets
Iressa 250mg - Gefitinib Tablets
Send Inquiry
Product Code : 122
Price And Quantity
  • Minimum Order Quantity
  • 10 Box
  • Price
  • 4402.70 INR
Product Specifications
  • Drug Type
  • External Use Drugs
  • Physical Form
  • Tablets
  • Function
  • Non-Small Cell Lung Cancer, Other
  • Dosage
  • 250mg
  • Suitable For
  • Aged Person, Adults, Women, Teenagers
  • Storage Instructions
  • Dry Palace
Product Description

USES

Iressa is used to treat some people with non-small cell lung cancer (NSCLC). It only works for cancers that have an abnormal form of a protein called epidermal growth factor receptor (EGFR). Tests are done on the cancer cells from a lung biopsy or previous surgery to check the level of EGFR.

IRESSA COMMON SIDE EFFECTS :

Acne; diarrhea; dry skin; loss of appetite; mouth ulcers; nausea; unusual weakness; vision problems; vomiting; weight loss.

Seek medical attention right away if any of these severe side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the eyelids, mouth, face, lips, or tongue); cough; dark urine; dizziness; eye irritation or pain; extreme fatigue; fever; persistent diarrhea; stomach pain; swelling of the ankles or feet; yellowing of the skin or eyes.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

Trade Information
  • Payment Terms
  • Western Union, Telegraphic Transfer (T/T), Letter of Credit at Sight (Sight L/C), Cheque, Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 100 Box Per Day
  • Delivery Time
  • 1 Week
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Main Domestic Market
  • All India

3S CORPORATION
X


Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.